Literature DB >> 7494265

Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent.

S Sakaguchi1, S Katamine, K Shigematsu, A Nakatani, R Moriuchi, N Nishida, K Kurokawa, R Nakaoke, H Sato, K Jishage.   

Abstract

Creutzfeldt-Jakob disease (CJD) is a transmissible neurodegenerative disease of humans caused by an unidentified infectious agent, the prion. To determine whether there was an involvement of the host-encoded prion protein (PrPc) in CJD development and prion propagation, mice heterozygous (PrP+/-) or homozygous (PrP-/-) for a disrupted PrP gene were established and inoculated with the mouse-adapted CJD agent. In keeping with findings of previous studies using other lines of PrP-less mice inoculated with scrapie agents, no PrP-/- mice showed any sign of the disease for 460 days after inoculation, while all of the PrP+/- and control PrP+/+ mice developed CJD-like symptoms and died. The incubation period for PrP+/- mice, 259 +/- 27 days, was much longer than that for PrP+/+ mice, 138 +/- 12 days. Propagation of the prion was barely detectable in the brains of PrP-/- mice and was estimated to be at a level at least 4 orders of magnitude lower than that in PrP+/+ mice. These findings indicate that PrPc is necessary for both the development of the disease and propagation of the prion in the inoculated mice. The proteinase-resistant PrP (PrPres) was undetectable in the brain tissues of the inoculated PrP-/- mice, while it accumulated in the affected brains of PrP+/+ and PrP+/- mice. Interestingly, the maximum level of PrPres in the brains of PrP+/- mice was about half of the level in the similarly affected brains of PrP+/+ mice, indicating that PrPres accumulation is restricted by the level of PrPc.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494265      PMCID: PMC189697     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development.

Authors:  M A Rudnicki; T Braun; S Hinuma; R Jaenisch
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

2.  Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.

Authors:  R Medori; P Montagna; H J Tritschler; A LeBlanc; P Cortelli; P Tinuper; E Lugaresi; P Gambetti
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

Review 3.  A 'unified theory' of prion propagation.

Authors:  C Weissmann
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

4.  Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture.

Authors:  R H Kimberlin; C A Walker
Journal:  J Gen Virol       Date:  1978-06       Impact factor: 3.891

5.  Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery.

Authors:  C Bernoulli; J Siegfried; G Baumgartner; F Regli; T Rabinowicz; D C Gajdusek; C J Gibbs
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

6.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

7.  Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice.

Authors:  S Sakaguchi; S Katamine; K Yamanouchi; M Kishikawa; R Moriuchi; N Yasukawa; T Doi; T Miyamoto
Journal:  J Gen Virol       Date:  1993-10       Impact factor: 3.891

8.  Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein.

Authors:  M A Whittington; K C Sidle; I Gowland; J Meads; A F Hill; M S Palmer; J G Jefferys; J Collinge
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

9.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

10.  Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents.

Authors:  J Tateishi; M Ohta; M Koga; Y Sato; Y Kuroiwa
Journal:  Ann Neurol       Date:  1979-06       Impact factor: 10.422

View more
  51 in total

1.  Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene.

Authors:  A Li; S Sakaguchi; R Atarashi; B C Roy; R Nakaoke; K Arima; N Okimura; J Kopacek; K Shigematsu
Journal:  Cell Mol Neurobiol       Date:  2000-10       Impact factor: 5.046

2.  B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice.

Authors:  F Montrasio; A Cozzio; E Flechsig; D Rossi; M A Klein; T Rülicke; A J Raeber; C A Vosshenrich; J Proft; A Aguzzi; C Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Effects of a brain-engraftable microglial cell line expressing anti-prion scFv antibodies on survival times of mice infected with scrapie prions.

Authors:  Koji Fujita; Yoshitaka Yamaguchi; Tsuyoshi Mori; Naomi Muramatsu; Takahito Miyamoto; Masashi Yano; Hironori Miyata; Akira Ootsuyama; Makoto Sawada; Haruo Matsuda; Ryuji Kaji; Suehiro Sakaguchi
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

Review 4.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

5.  Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia.

Authors:  Eckhard Flechsig; Ivan Hegyi; Rainer Leimeroth; Armando Zuniga; Daniela Rossi; Antonio Cozzio; Petra Schwarz; Thomas Rülicke; Jürgen Götz; Adriano Aguzzi; Charles Weissmann
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

6.  Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease.

Authors:  J Kopacek; S Sakaguchi; K Shigematsu; N Nishida; R Atarashi; R Nakaoke; R Moriuchi; M Niwa; S Katamine
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 8.  Prion diseases and the gastrointestinal tract.

Authors:  G A Davies; Adam R Bryant; John D Reynolds; Frank R Jirik; Keith A Sharkey
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

Review 9.  Grafting mouse brains: from neurocarcinogenesis to neurodegeneration.

Authors:  A Aguzzi
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

10.  Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.

Authors:  N Kellershohn; M Laurent
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.